Explaining TNM Cancer Staging in 'Demystifying the Darkness'

In the complex and often overwhelming world of oncology, words like "stage" are frequently tossed around by medical professionals and patients alike. However, the true clinical meaning of the term is often lost in translation. In the latest episode of her vlog series, "Demystifying the Darkness," Dr. Susan MacDonald, a urologist and stage 4 breast cancer survivor, breaks down the nuances of cancer staging to help patients better advocate for themselves.

The Common Understanding vs. Clinical Reality

MacDonald begins by acknowledging the "colloquial" use of the word. For most people, hearing a "stage" (typically ranked 1 through 4) is a shorthand for how much a tumor has spread. While this provides a general sense of the disease's progression, MacDonald explains that doctors use a much more specific, multidimensional framework known as the TNM staging system.

"When a doctor says stage, typically they're talking about TNM staging," MacDonald explains. This system provides a granular look at the disease by evaluating three distinct factors:

• T (Tumor): Refers to the size and extent of the primary tumor.
• N (Nodes): Indicates whether the cancer has spread to nearby lymph nodes.
• M (Metastasis): Determines if the cancer has spread to distant parts of the body.

The Complexity of the Scorecard

Each of these categories is assigned a number. The combination of these numbers is what eventually leads to an overall stage designation. However, MacDonald notes that the relationship between these numbers isn't always linear.

"For some diseases, you can have a very locally aggressive [tumor], like a high T4, but still be overall stage 1," she notes. This distinction is vital for patients to understand, as a "high" number in one category doesn't always equate to the most advanced stage of the disease.

Why Staging Matters

Staging is not just about labeling the disease; it is the primary tool doctors use to determine the most effective course of treatment. By identifying exactly where the cancer is and how it is behaving, oncology teams can decide between localized treatments, like surgery or radiation, and systemic treatments, like chemotherapy or immunotherapy.

As MacDonald has discussed in previous episodes, such as her deep dive into the different types of cancer, knowledge is a form of empowerment. By understanding that "stage 4" or "stage 1" is the result of a specific formula (TNM), patients can ask more pointed questions about their specific diagnosis.

A Peer-to-Peer Approach

MacDonald’s unique perspective as both a physician and a patient allows her to bridge the gap between clinical jargon and the patient experience. While she acknowledges that the TNM system can be "a bit confusing," she emphasizes that demystifying these terms is the first step in "lighting the way" through the darkness of a cancer diagnosis.

By breaking down these barriers, MacDonald continues to provide a vital resource for the cancer community, ensuring that patients are not just recipients of care, but informed participants in their own health journeys.

This piece reflects the author’s personal experience and perspective. For medical advice, please consult your health care provider.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.